56 results
PRE 14A
AXLA
Axcella Health Inc.
7 Aug 23
Preliminary proxy
4:15pm
for the portfolio, strategy and operations functions within Pfizer’s BioTherapeutics Division and ensured efficient advancement of protein therapeutics … on technology and operations strategy, the management of innovation and intellectual property, and competitive strategy. For more than two decades, he has
8-K
EX-99.1
gfr85m w1
30 Mar 23
Axcella Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
8:22am
8-K
EX-99.1
ld6m8uqcyknmxwow08
15 Dec 22
Axcella Announces Program Reprioritization and Corporate Restructuring Move Positions Company to Best Focus on Long COVID Program
7:00am
8-K
EX-99.1
nnh8t8cjfaq1lcmog
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
8-K
rrvkyi
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
424B5
71th9x9 rp76m4oeha6x
13 Oct 22
Prospectus supplement for primary offering
7:55am
8-K
EX-99.2
k7vvvp2 hj
29 Sep 22
Regulation FD Disclosure
9:15am
8-K
EX-99.1
mdz1vm pr
29 Sep 22
Regulation FD Disclosure
9:15am
8-K
EX-99.2
o7rhve4uy 40umfdld
2 Aug 22
Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID
4:06pm
8-K
jwh804ko n5
25 May 22
Departure of Directors or Certain Officers
5:01pm